FIELD: medicine. SUBSTANCE: method involves applying 4-6% aqueous solution of heptapeptide Met-Glu-His-Phe-Gly-Pro by means of its intranasal application in the amount of 1-4 drops in each nasal canal 1-4 times per day during 6-12 days. Patients of medium severity or severe insults take the heptapeptide in daily doses like 9-13 mg and 15-24 mg, respectively. EFFECT: favorable influence on recovery processes. 2 cl, 2 dwg, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR TREATING ISCHEMIC INSULT AND METHOD FOR THERAPY | 2002 |
|
RU2251429C2 |
| METHOD TO TREAT ACUTE ISCHEMIC INSULT | 1992 |
|
RU2082398C1 |
| NOOTROPIC DRUG AND PHARMACEUTICAL NOOTROPIC COMPOSITION | 1994 |
|
RU2045958C1 |
| METHOD OF CEREBRAL ISCHEMIC INSULT TREATMENT | 1996 |
|
RU2145895C1 |
| METHOD OF SCREENING PHARMACOLOGICAL COMPOUNDS ACCORDING TO NEUROPROTECTIVE ACTIVITY | 2009 |
|
RU2383615C1 |
| METHOD FOR ASSESSMENT OF NEUROTROPHIN GENES EXPRESSION | 2009 |
|
RU2383619C1 |
| MEANS AND DEVICE FOR TREATING THE CASES OF OPTIC NERVE NEURITIS HAVING INFLAMMATORY, TOXICOALLERGIC OR VASCULAR ETIOLOGY AND OPTIC NERVE ATROPHY | 1999 |
|
RU2157258C1 |
| METHOD FOR TREATING ACUTE CEREBRAL STROKE CASES | 2005 |
|
RU2268064C1 |
| METHOD OF TREATING ACUTE ISCHEMIC AND HEMORRHAGIC CEREBROVASCULAR DISEASE | 2010 |
|
RU2477637C2 |
| METHOD FOR TREATMENT OF NERVOUS SYSTEM DISORDER IN CHILDREN OF YOUNGEST AGE AND PHARMACEUTICAL COMPOSITION | 2003 |
|
RU2241487C1 |
